iwi Supplements

Our assessment

Based on FDA adverse event data, pyridoxal 5'-phosphate (vitamin B6) has a generally favorable safety profile. The data provided does not include any adverse event reports for this specific supplement, indicating that reported safety issues are minimal in the available FDA database. This aligns with the established understanding that vitamin B6 is a water-soluble vitamin with low toxicity NIH ODS ↗.

How it works

Pyridoxal 5'-phosphate is the active coenzyme form of vitamin B6. It plays a critical role in over 100 enzyme reactions in the body, primarily related to protein metabolism, neurotransmitter synthesis, and red blood cell formation NIH ODS ↗. As the active form, it is directly usable by the body without needing to be converted in the liver, which may be beneficial for individuals with certain liver conditions NIH DSLD ↗.

Safety profile

The FDA adverse event data for this product contains zero reported side effects. Data not available on specific adverse event counts from this source. It is important to note that while this dataset shows no reports, general vitamin B6 toxicity is associated with long-term, high-dose supplementation (typically >200 mg daily) leading to sensory neuropathy NIH ODS ↗. No drug interactions were identified in the provided data. Caution is advised for individuals taking levodopa for Parkinson's disease, as vitamin B6 can reduce its effectiveness, though this information is not from the provided data NIH ODS ↗.

Our recommendation

For most adults, a standard dose of 1.3-1.7 mg daily of vitamin B6 is adequate NIH ODS ↗. If using pyridoxal 5'-phosphate as a supplement, stick to recommended doses. The provided FDA data shows no safety signals for this specific product, but long-term use of high doses should be avoided to prevent potential neurotoxicity NIH ODS ↗. Monitor for any unusual symptoms and consult a healthcare provider before starting supplementation, especially if you are on other medications FDA FAERS ↗.